Koyfin Home > Directory > Health Care > Adamas Pharma > Long-Term Investments

Adamas Pharma Long-Term Investments Chart (ADMS)

Adamas Pharma annual/quarterly Long-Term Investments from 2014 to 2018.
  • Adamas Pharma Long-Term Investments for the quarter ending September 09, 2018 was $22m a 86.24% increase of 19m year over year
  • Adamas Pharma Long-Term Investments for the last 12 months ending September 09, 2018 was $22m a 86.24% increase of 19m year over year
  • Adamas Pharma Annual Long-Term Investments for 2017 was $3m a -645.30% decrease of -19m from 2016
  • Adamas Pharma Annual Long-Term Investments for 2016 was $22m a 40.94% increase of 9m from 2015
  • Adamas Pharma Annual Long-Term Investments for 2015 was $13m a -176.22% decrease of -23m from 2014
Other Cash Flow Metrics:
  • Adamas Pharma Cash Flow from Operations for the quarter ending December 12, 2018 was $-24m a -5.06% increase of 1m year over year
  • Adamas Pharma Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-33m a 50.48% decrease of -17m year over year
  • Adamas Pharma Total Revenue for the quarter ending September 09, 2018 was $11m a 94.65% increase of 10m year over year
View Chart On Koyfin

Quarterly ADMS Long-Term Investments Data

09/2018$22m
06/2018$53m
03/2018$88m
12/2017$3m
09/2017$7m
06/2017$17m
03/2017$10m
12/2016$22m
09/2016$44m
06/2016$2m

Annual ADMS Long-Term Investments Data

2017$3m
2016$22m
2015$13m
2014$36m